News

Fierce Biotech11d
Charles River launches strategic review and shakes up board amid regulatory uncertainty, sliding revenue
Charles River CEO James Foster had previously attributed the 2024 revenue dip to decreased demand from biopharma clients. In ...
Charles River agrees with Elliott to add new directors, review business
Pharmaceutical company Charles River Laboratories has reached a settlement with activist investor Elliott Investment ...
Activist Elliott reaches key agreement with Charles River. Here are three ways to create value
Charles River Laboratories is an early-stage contract research company. The company engages in laboratory animal medicine and ...
Yahoo Finance20d
Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort
WILMINGTON, Mass., April 29, 2025--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the initial cohort of its Charles River Incubator Program (CIP).
Benzinga.com11d
Charles River Laboratories' Q1 Earnings Beat Consensus, Stock Trades Higher On Signs Of Demand Stabilization
Reserve your free spot now. Charles River CEO James Foster cited a an improvement in DSA booking activity “to the highest level in two years.” Guidance: Charles River raised its 2025 outlook ...
NBC Los Angeles9d
Activist Elliott reaches key agreement with Charles River. Here are three ways to create value
Business: Charles River Laboratories is an early-stage contract research company. The company engages in laboratory animal medicine and science (research model technologies), and it has developed ...
NBC 6 South Florida9d
Activist Elliott reaches key agreement with Charles River. Here are three ways to create value
On May 6, Elliott and Charles River Laboratories entered into a cooperation agreement in which four incumbent directors won't seek re-election and the following four individuals will be appointed ...